| Sterling Biotech has reported a standalone total income from operations of Rs 102.06 crore and a net loss of Rs 90.35 crore for the quarter ended Mar '15. Other income for the quarter was Rs 1.43 crore. | | For the quarter ended Mar 2014 the standalone total income from operations was Rs 188.83 crore and net loss was Rs 103.33 crore, and other income Rs 0.62 crore. | | Sterling Bio shares closed at 6.20 on May 15, 2015 (NSE) and has given -22.98% returns over the last 6 months and -56.18% over the last 12 months. |
|
| | Sterling Biotech | | Standalone Quarterly Results | -------- in Rs. Cr. -------- |
|
| Mar '15 | Dec '14 | | | Mar '14 | | Net Sales/Income from operations | 100.63 | 121.63 | | | 188.21 | | Other Operating Income | 1.43 | 0.75 | | | 0.62 | | Total Income From Operations | 102.06 | 122.38 | | | 188.83 | | EXPENDITURE | | | | | | | Consumption of Raw Materials | 173.30 | 87.97 | | | 92.88 | | Purchase of Traded Goods | -- | -- | | | -- | | Increase/Decrease in Stocks | -105.49 | 0.47 | | | 33.62 | | Power & Fuel | -- | -- | | | -- | | Employees Cost | 12.27 | 12.17 | | | 13.80 | | Depreciation | 70.50 | 84.80 | | | 63.89 | | Excise Duty | -- | -- | | | -- | | Admin. And Selling Expenses | -- | -- | | | -- | | R & D Expenses | -- | -- | | | -- | | Provisions And Contingencies | -- | -- | | | -- | | Exp. Capitalised | -- | -- | | | -- | | Other Expenses | 8.82 | 9.32 | | | 11.80 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -57.34 | -72.35 | | | -27.15 | | Other Income | -- | -- | | | -- | | P/L Before Int., Excpt. Items & Tax | -57.34 | -72.35 | | | -27.15 | | Interest | 76.39 | 87.60 | | | 125.81 | | P/L Before Exceptional Items & Tax | -133.74 | -159.95 | | | -152.96 | | Exceptional Items | -- | -- | | | -- | | P/L Before Tax | -133.74 | -159.95 | | | -152.96 | | Tax | -43.39 | -51.89 | | | -49.63 | | P/L After Tax from Ordinary Activities | -90.35 | -108.06 | | | -103.33 | | Prior Year Adjustments | -- | -19.32 | | | -- | | Extra Ordinary Items | -- | -- | | | -- | | Net Profit/(Loss) For the Period | -90.35 | -127.38 | | | -103.33 | | Equity Share Capital | 27.20 | 27.20 | | | 26.79 | | Reserves Excluding Revaluation Reserves | -- | -- | | | -- | | Equity Dividend Rate (%) | -- | -- | | | -- | | EPS Before Extra Ordinary | | | | | | | Basic EPS | -3.32 | -3.97 | | | -3.86 | | Diluted EPS | -2.09 | -2.50 | | | -2.39 | | EPS After Extra Ordinary | | | | | | | Basic EPS | -3.32 | -3.97 | | | -3.86 | | Diluted EPS | -2.09 | -2.50 | | | -2.39 | | Public Share Holding | | | | | | | No Of Shares (Crores) | 13.55 | 13.55 | | | 13.19 | | Share Holding (%) | 49.82 | 49.82 | | | 49.23 | | Promoters and Promoter Group Shareholding | | | | | | | a) Pledged/Encumbered | | | | | | | - Number of shares (Crores) | 5.08 | 5.08 | | | 5.08 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 55.94 | 55.94 | | | 55.94 | | - Per. of shares (as a % of the total Share Cap. of the company) | 18.68 | 18.68 | | | 18.97 | | b) Non-encumbered | | | | | | | - Number of shares (Crores) | 4.00 | 4.00 | | | 4.00 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 44.06 | 44.06 | | | 44.06 | | - Per. of shares (as a % of the total Share Cap. of the company) | 14.71 | 14.71 | | | 14.94 | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
